Abbott Recalls FreeStyle Readers
On April 4, 2023, FDA posted an announcement to its Medical Device Recalls page identifying Abbott’s recall on the FreeStyle Libre family of readers used with the FreeStyle Libre, FreeStyle Libre 14 day, and FreeStyle Libre 2 Flash CGMs for risk of extreme heat and fire as a Class I Recall (view FDA announcement). Below, FENIX provides brief insight into the impact of the recall.
About The Author
Matthew has been a thought leader in the high-growth therapeutic areas of diabetes and cardiovascular medicine since 2006, making regular attendance at large and small CV/met scientific meetings and an architect of novel methods for assessing market opportunities. He has over a decade of experience in leading CV/met consulting engagements, is a published author in PM360 and Diabetes Technology & Therapeutics, and has been quoted in The Pink Sheet on anti-thrombotics.
If you receive our email blasts, you already have an account. Log in now
You can read the article’s full content online after purchase.